Overview

Cavas S. Pavri advises U.S. and international public and private companies and investment banks in securities offerings, corporate governance and general corporate matters. He builds a level of trust with clients through his calm demeanor and organized approach, which he brings while handling both daily business matters and tense, high-stakes transactions.

Cavas assists public and private companies in their capital-raising activities, including public offerings, private placements of equity and debt securities, and mergers and acquisitions.

He counsels public companies in the preparation of 1933 and 1934 Act filings, stock exchange compliance matters and shareholder matters. He also regularly works with investment banks on a variety of complex securities transactions, including IPOs, registered direct offerings, confidentially marketed public offerings and PIPEs.

As part of Schiff Hardin’s China Practice, Cavas has significant experience advising Chinese clients with securities listed on major U.S. securities exchanges and that access the U.S. equity markets. He also advises investment banks doing business with Chinese companies.

  • Experience

    • Representing investment banking clients as underwriters’ counsel in IPOs and follow-on public offerings of securities. Completing numerous “overnight” registered offerings as well as confidentially marketed public offerings.
    • Serving as outside securities counsel to several public companies, including companies listed on the NYSE, Nasdaq and NYSE MKT.
    • Advising public company clients regarding SEC regulations and corporate governance matters.
    • Representing public company clients in IPOs and follow-on public offerings of common stock.
  • Credentials

    Education

    • Georgetown University Law Center, LL.M., 1998
    • University of Houston Law Center, J.D., 1997
    • University of Texas at Austin, B.B.A., 1994

    Bar Admissions

    • Texas
    • Pennsylvania
          • Insights

            TITLE
            News Release

            Schiff Hardin Advises on Public Offerings in Pharma, Tech Sectors

            In the last 60 days, Schiff Hardin advised on the initial public offerings (IPO) for two companies and a public offering for another company, two in pharmaceuticals and one in the tech sector.

            News Release

            Schiff Hardin Advises The Benchmark Company as Underwriter in $12 Million IPO of ADSs

            Schiff Hardin advised The Benchmark Company as managing underwriter in Biofrontera AG’s initial public offering of 1.2 million American depositary shares (ADSs), raising $12 million, and the Nasdaq listing of Biofrontera’s ADSs.

            Trending Legal Issue

            SEC Proposes Clawback Rules

            On July 1, 2015, the Securities and Exchange Commission (SEC) issued a proposed rule that implements the clawback provisions of the Dodd-Frank Act.

            Other Publications

            • “The JOBS Act: SEC Guidance on the Changes to the Registration and Deregistration Requirements under the Exchange Act, (co-author) Securities Alert (Jul. 2, 2012)
            • “Confidentiality Agreements and Standstill Provisions; the Delaware Chancery Court Broadly Construes Confidentiality Agreements and Enjoins a Hostile Bid Despite the Absence of Standstill Provisions Relating to Stock Transactions,” (co-author) Securities Alert (Jun. 26, 2012)
            • “The JOBS Act: SEC Guidance on the Confidential Submission Process,” (co-author) Securities Alert (May 10, 2012)
            • “SEC Approves Nasdaq Proposal for Alternative Minimum Bid Price Listing Requirement,” (co-author) Securities Offerings and Regulation Alert (May 7, 2012)